BioMarin Pharmaceutical Inc. (BMRN)

Sector:Health Care
Super Investor Stats:
Ownership count:2
Ownership rank:348
% of all portfolios:0.039%
Hold Price * :$70.29
History Portfolio Manager Activity Share change % change to portfolio ▲
Q3  2024
≡ Torray Funds Sell 100.00% 16,855 0.21
≡ Viking Global Investors Add 38.08% 2,689,729 0.69
Q2  2024
≡ Torray Funds Add 13.61% 2,019 0.03
≡ Viking Global Investors Add 10.09% 647,276 0.20
Q1  2024
≡ Torray Funds Add 1.15% 168 0.00
≡ Viking Global Investors Add 31.23% 1,526,834 0.50
≡ Daniel Loeb - Third Point Sell 100.00% 385,000 0.56
Q4  2023
≡ Torray Funds Add 3.14% 446 0.01
≡ Viking Global Investors Add 15.99% 673,998 0.24
≡ Daniel Loeb - Third Point Buy 385,000 0.56
Q3  2023
≡ Dodge & Cox Add 0.53% 47,000 0.00
≡ Viking Global Investors Add 1.41% 58,671 0.02
≡ Torray Funds Add 29.51% 3,241 0.05
Q2  2023
≡ Dodge & Cox Add 0.36% 32,200 0.00
≡ Torray Funds Add 0.96% 104 0.00
≡ Viking Global Investors Add 91.68% 1,988,168 0.71
Q1  2023
≡ Torray Funds Add 0.40% 43 0.00
≡ Viking Global Investors Reduce 58.88% 3,105,003 1.42
Q4  2022
≡ Torray Funds Reduce 4.12% 466 0.01
≡ Dodge & Cox Reduce 1.89% 170,400 0.02
≡ Viking Global Investors Add 3.42% 174,456 0.09
Q3  2022
≡ Torray Funds Reduce 2.33% 269 0.00
≡ Dodge & Cox Add 0.21% 18,500 0.00
≡ Viking Global Investors Add 0.92% 46,571 0.02
Q2  2022
≡ Torray Funds Reduce 0.16% 18 0.00
≡ Viking Global Investors Add 34.65% 1,300,200 0.49
Q1  2022
≡ Torray Funds Reduce 5.31% 650 0.01
≡ Viking Global Investors Add 30.75% 882,446 0.28
Q4  2021
≡ Lee Ainslie - Maverick Capital Sell 100.00% 5,833 0.00
≡ Torray Funds Reduce 25.40% 4,166 0.05
≡ Viking Global Investors Buy 2,869,947 0.74
Q3  2021
≡ Lee Ainslie - Maverick Capital Reduce 9.98% 647 0.00
≡ Torray Funds Add 1.26% 204 0.00
≡ Dodge & Cox Add 6.08% 515,300 0.04
Q2  2021
≡ Torray Funds Add 0.88% 142 0.00
≡ Lee Ainslie - Maverick Capital Buy 6,480 0.01
≡ Dodge & Cox Add 25.51% 1,721,565 0.16
Q1  2021
≡ Dodge & Cox Add 22.19% 1,225,735 0.12
≡ Torray Funds Reduce 75.72% 50,070 0.59
Q4  2020
≡ Torray Funds Reduce 3.31% 2,263 0.03
≡ Dodge & Cox Add 33.33% 1,380,965 0.17
Q3  2020
≡ Torray Funds Add 26.48% 14,320 0.20
≡ Dodge & Cox Add 78.10% 1,816,835 0.23
Q2  2020
≡ Dodge & Cox Reduce 7.73% 195,000 0.04
≡ Torray Funds Reduce 10.69% 6,472 0.15
≡ Viking Global Investors Sell 100.00% 1,453,625 0.64
Q1  2020
≡ Dodge & Cox Reduce 14.71% 435,000 0.07
≡ Viking Global Investors Reduce 10.37% 168,114 0.07
≡ Torray Funds Add 7.14% 4,037 0.08
Q4  2019
≡ Dodge & Cox Buy 2,956,325 0.34
≡ Viking Global Investors Reduce 46.97% 1,436,365 0.57
≡ Torray Funds Reduce 72.02% 145,450 2.11
Q3  2019
≡ Torray Funds Add 0.47% 954 0.01
≡ Viking Global Investors Add 18.06% 467,753 0.16
Q2  2019
≡ Torray Funds Reduce 8.67% 19,086 0.17
≡ Viking Global Investors Reduce 49.50% 2,538,558 0.98
Q1  2019
≡ Torray Funds Reduce 2.03% 4,552 0.04
Q4  2018
≡ Torray Funds Reduce 5.32% 12,632 0.13
Q2  2013
≡ Meridian Contrarian Fund Sell 100.00% 40,700 0.38
Q1  2013
≡ Meridian Contrarian Fund Reduce 69.03% 90,700 0.85
Q4  2012
≡ Meridian Contrarian Fund Reduce 60.99% 205,400 1.63
Q2  2012
≡ Meridian Contrarian Fund Add 9.35% 28,800 0.18
Q1  2012
≡ Meridian Contrarian Fund Reduce 3.51% 11,200 0.06
Q4  2011
≡ Meridian Contrarian Fund Reduce 8.49% 29,600 0.15
Q1  2011
≡ Meridian Contrarian Fund Reduce 51.54% 371,000 1.07
Q3  2010
≡ Meridian Contrarian Fund Reduce 9.56% 76,100 0.21
Q1  2010
≡ Meridian Contrarian Fund Add 20.83% 137,200 0.35
Q3  2009
≡ Meridian Contrarian Fund Buy 658,700 1.33
Q2  2009
≡ Bill & Melinda Gates Foundation Trust Sell 100.00% 104,856 0.02
Q1  2009
≡ Bill & Melinda Gates Foundation Trust Buy 104,856 0.02

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.